Here are Friday's biggest analyst calls: Anthropic, SpaceX, Tesla, Apple, Netflix, MSG Rangers, United Health & more
Analysts made several ratings changes: Seaport initiated Anthropic as neutral, citing revenue growth concerns. Roth initiated STMicroelectronics as buy with a $58 target. UBS reiterated Apple as neutral, noting declining iPhone Duo wait times. Bernstein reiterated Netflix as outperform, expecting double-digit growth. HSBC upgraded Tesla to hold, questioning a potential SpaceX merger. TD Cowen upgraded UnitedHealth and Humana to buy, citing growth prospects.
How this was made

The 30-second read
Why it matters
While each recommendation provides fresh perspective, the collective nature limits immediate trading impact.
Market read
Analyst opinion roundup with modest trading relevance; few catalysts beyond rating changes.
What to watch
Potential macro headwinds could dampen the impact of individual upgrades.
Background
The article compiles Friday's analyst initiations, upgrades, and downgrades across a range of companies.
Ticker impact
HSBC upgraded Tesla to hold, citing uncertainty over a potential Tesla‑SpaceX merger.
likely pressure as investors reassess merger rationale
Analyst downgrade without new fundamentals may weigh on price.
UBS reiterated Apple as neutral, noting a ~21‑day decline in iPhone wait‑times.
limited upside as supply constraints ease
No rating change; only supply data update.
Bernstein reiterated Netflix as outperform, arguing double‑digit growth is possible in 2027.
potential modest upside on growth expectations
Reiteration without target change; limited immediate impact.
TD Cowen upgraded UnitedHealth to buy, citing mid‑high‑teens EPS growth through 2028.
possible upward pressure from upgrade
Upgrade with growth narrative could attract buyers.
Roth initiated coverage of STMicroelectronics with a Buy rating and $58 price target.
upward pressure from fresh buy recommendation
Analyst initiation often lifts stock.
Macquarie upgraded PDD Holdings to outperform, raising its target 8% on profitability signs.
potential upside as investors price higher target
Target raise and upgrade may move price.
Truist upgraded Evolent to buy from hold, keeping a $6 price target.
moderate upside from upgrade
Upgrade without target change limits impact.
TD Cowen upgraded Humana to buy, highlighting a clear EPS growth path.
upward pressure from upgrade
Upgrade may attract interest but limited catalyst.
Market effects
Analyst upgrades across tech, health, and industrials may lift sector sentiment.
US equities may see modest gains from multiple buy upgrades.
Limited; primarily US‑focused analyst activity.
Counterpoint
Several upgrades may be premature given broader market volatility.
Key entities
- analystHSBC
Upgraded Tesla to hold, citing merger uncertainty.
- analystUBS
Reiterated Apple as neutral, noting improved iPhone supply.
- analystBernstein
Reiterated Netflix as outperform.

